Application | Ubigene

Application

All (311)
Case Study (65)
Expert Insights - Cell Culture (25)
Expert Insights - Cell Application (55)
Expert Insights - CRISPR Library (61)
Gene Editing Practical Tips (38)
Others (67)

Point Mutation Cell Line Generation: HDR vs. Base vs. Prime Editing

Compare HDR, base editing, and prime editing for point mutation cell line generation. Learn which method fits your target edit, cell type, and desired genotype.

IF=12.2 | ENO2 Drives Tumor Progression in VHL-Deficient Kidney Cancer

Explore how ENO2 drives VHL-deficient kidney cancer through lactate and interferon signaling, with Ubigene lentiviral vectors supporting mechanistic research.

Nanogel Stiffness Reprograms TAMs and Suppresses Tumor Growth

Discover how stiff nanogels reprogram tumor-associated macrophages and suppress liver tumor growth, with Ubigene H22-Luc cells enabling in vivo tumor monitoring.

NLRP3 R262W THP-1 Cells for Inflammasome Activation Research

Explore how NLRP3 R262W THP-1 cells support inflammasome research, CRISPR screening, and compound evaluation in CAPS-associated disease models.

Customer Publication Highlights: How Ubigene KO Cell Lines Advance Disease Research from Cancer to Immunology

Explore how Ubigene knockout cell lines support research into cancer, immunity, viral infection, and cell death through selected customer publications.